Jansen, M., Kessels, J., Merks, I., Nelemans, P., Kelleners‐Smeets, N., Mosterd, K., & Essers, B. (2020). A trial‐based cost‐effectiveness analysis of topical 5‐fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands. Br J Dermatol.
Chicago Style CitationJansen, M.H.E., J.P.H.M Kessels, I. Merks, P.J Nelemans, N.W.J Kelleners‐Smeets, K. Mosterd, i B.A.B Essers. "A Trial‐based Cost‐effectiveness Analysis of Topical 5‐fluorouracil Vs. Imiquimod Vs. Ingenol Mebutate Vs. Methyl Aminolaevulinate Conventional Photodynamic Therapy for the Treatment of Actinic Keratosis in the Head and Neck Area Performed in the Netherlands." Br J Dermatol 2020.
Cita MLAJansen, M.H.E., et al. "A Trial‐based Cost‐effectiveness Analysis of Topical 5‐fluorouracil Vs. Imiquimod Vs. Ingenol Mebutate Vs. Methyl Aminolaevulinate Conventional Photodynamic Therapy for the Treatment of Actinic Keratosis in the Head and Neck Area Performed in the Netherlands." Br J Dermatol 2020.